_id
69104cc8ccc777a4e85d52a2
Ticker
CFRXQ
Name
ContraFect Corporation
Exchange
PINK
Address
28 Wells Avenue, Yonkers, NY, United States, 10701
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.contrafect.com
Description
ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus. The company also developing CF-370, an investigational anti-bacterial therapeutic candidate, which is in Phase 1 clinical trials to treat pseudomonas aeruginosa infections, such as ventilator associated pneumonia, blood stream infections, complicated urinary tract infections, and surgery carry infections. It also developing CF-296, an osteomyelitis and PJI which is in preclinical trailers for the treatment of joint infections. In addition, the company developing Exebacase for the treatment of persistent bacteremia caused by methicillin-resistant staphylococcus aureus in COVID-19 patients. Further, It develops CF-296, an engineered lysin, used for treatment of the invasive infections caused by staphylococcus aureus including biofilm-related infections in prosthetic joints and indwelling devices and osteomyelitis. The company has a license agreement with The Rockefeller University to identify novel lysin therapeutic candidates targeting gram-negative pathogens. ContraFect Corporation was incorporated in 2008 and is headquartered in Yonkers, New York. On December 4, 2023, ContraFect Corporation filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.
Last Close
0.0001
Volume
15000
Current Price
0
Change
0
Last Updated
2026-01-02T11:13:37.695Z
Image
-
Ipo Date
-
Market Cap
107
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2023-09-30
Revenue
0
Cost Of Revenue
39000
Gross Profit
-39000
Operating Expenses
6638000
Operating Income
-6677000
Interest Expense
-
Pretax Income
-5359000
Net Income
-5359000
Eps
-0.5006164055517883
Dividends Per Share
-
Shares Outstanding
10704803
Income Tax Expense
-
EBITDA
-6638000
Operating Margin
-
Total Other Income Expense Net
1318000
Cash
5413000
Short Term Investments
0
Receivables
100000
Inventories
-
Total Current Assets
6520000
Property Plant Equipment
2500000
Total Assets
9125000
Payables
8179000
Short Term Debt
680000
Long Term Debt
-
Total Liabilities
14884000
Equity
-5759000
Bs_currency_symbol
USD
Depreciation
39000
Change In Working Capital
-2849000
Cash From Operations
-8669000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-340000
Net Change In Cash
-9009000
Cf_currency_symbol
USD
PE
-
PB
-
ROE
93.05434971349193
ROA
-58.728767123287675
FCF
-8669000
Fcf Percent
-
Piotroski FScore
0
Health Score
42
Deep Value Investing Score
2.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
2
Net Net Investing Score
2
Quality Investing Score
3
Value Investing Score
3
Quarters > 0 > quarter
2023-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
39000
Quarters > 0 > income Statement > gross Profit
-39000
Quarters > 0 > income Statement > operating Expenses
6638000
Quarters > 0 > income Statement > operating Income
-6677000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-5359000
Quarters > 0 > income Statement > net Income
-5359000
Quarters > 0 > income Statement > eps
-0.5006164055517883
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
10704803
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-6638000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1318000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
5413000
Quarters > 0 > balance Sheet > short Term Investments
0
Quarters > 0 > balance Sheet > receivables
100000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
6520000
Quarters > 0 > balance Sheet > property Plant Equipment
2500000
Quarters > 0 > balance Sheet > total Assets
9125000
Quarters > 0 > balance Sheet > payables
8179000
Quarters > 0 > balance Sheet > short Term Debt
680000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
14884000
Quarters > 0 > balance Sheet > equity
-5759000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-5359000
Quarters > 0 > cash Flow > depreciation
39000
Quarters > 0 > cash Flow > change In Working Capital
-2849000
Quarters > 0 > cash Flow > cash From Operations
-8669000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-340000
Quarters > 0 > cash Flow > net Change In Cash
-9009000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.5006164055517883
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
93.05434971349193
Quarters > 0 > ratios > ROA
-58.728767123287675
Quarters > 0 > ratios > FCF
-8669000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2023-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
41000
Quarters > 1 > income Statement > gross Profit
-41000
Quarters > 1 > income Statement > operating Expenses
7934000
Quarters > 1 > income Statement > operating Income
-7975000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-7568000
Quarters > 1 > income Statement > net Income
-7568000
Quarters > 1 > income Statement > eps
-1.9395982253496364
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
3901839
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-7934000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
407000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
14422000
Quarters > 1 > balance Sheet > short Term Investments
0
Quarters > 1 > balance Sheet > receivables
571000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
16514000
Quarters > 1 > balance Sheet > property Plant Equipment
2633000
Quarters > 1 > balance Sheet > total Assets
19252000
Quarters > 1 > balance Sheet > payables
11557000
Quarters > 1 > balance Sheet > short Term Debt
677000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
20360000
Quarters > 1 > balance Sheet > equity
-1108000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-7568000
Quarters > 1 > cash Flow > depreciation
41000
Quarters > 1 > cash Flow > change In Working Capital
-1151000
Quarters > 1 > cash Flow > cash From Operations
-8151000
Quarters > 1 > cash Flow > capital Expenditures
15000
Quarters > 1 > cash Flow > cash From Investing
1985000
Quarters > 1 > cash Flow > cash From Financing
8722000
Quarters > 1 > cash Flow > net Change In Cash
2556000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-1.9395982253496364
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
683.0324909747293
Quarters > 1 > ratios > ROA
-39.3102015375026
Quarters > 1 > ratios > FCF
-8166000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2023-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
40000
Quarters > 2 > income Statement > gross Profit
-40000
Quarters > 2 > income Statement > operating Expenses
8818000
Quarters > 2 > income Statement > operating Income
-8858000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-1371000
Quarters > 2 > income Statement > net Income
-1371000
Quarters > 2 > income Statement > eps
-0.6940099500069856
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
1975476
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-8818000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
7487000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
11866000
Quarters > 2 > balance Sheet > short Term Investments
2025000
Quarters > 2 > balance Sheet > receivables
1700000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
17698000
Quarters > 2 > balance Sheet > property Plant Equipment
2749000
Quarters > 2 > balance Sheet > total Assets
20552000
Quarters > 2 > balance Sheet > payables
10828000
Quarters > 2 > balance Sheet > short Term Debt
674000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
23689000
Quarters > 2 > balance Sheet > equity
-3137000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-1371000
Quarters > 2 > cash Flow > depreciation
40000
Quarters > 2 > cash Flow > change In Working Capital
-1031000
Quarters > 2 > cash Flow > cash From Operations
-8798000
Quarters > 2 > cash Flow > capital Expenditures
5000
Quarters > 2 > cash Flow > cash From Investing
2745000
Quarters > 2 > cash Flow > cash From Financing
9012000
Quarters > 2 > cash Flow > net Change In Cash
2959000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.6940099500069856
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
43.7041759642971
Quarters > 2 > ratios > ROA
-6.670883612300506
Quarters > 2 > ratios > FCF
-8803000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2022-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
39000
Quarters > 3 > income Statement > gross Profit
-39000
Quarters > 3 > income Statement > operating Expenses
6664000
Quarters > 3 > income Statement > operating Income
-6703000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-9839000
Quarters > 3 > income Statement > net Income
-9839000
Quarters > 3 > income Statement > eps
-16.14035663314687
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
609590
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-6665000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-3137000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
8907000
Quarters > 3 > balance Sheet > short Term Investments
4775000
Quarters > 3 > balance Sheet > receivables
2600000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
17706000
Quarters > 3 > balance Sheet > property Plant Equipment
2868000
Quarters > 3 > balance Sheet > total Assets
20679000
Quarters > 3 > balance Sheet > payables
13671000
Quarters > 3 > balance Sheet > short Term Debt
671000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
32531000
Quarters > 3 > balance Sheet > equity
-11852000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-9839000
Quarters > 3 > cash Flow > depreciation
39000
Quarters > 3 > cash Flow > change In Working Capital
-4509000
Quarters > 3 > cash Flow > cash From Operations
-9968000
Quarters > 3 > cash Flow > capital Expenditures
43000
Quarters > 3 > cash Flow > cash From Investing
8067000
Quarters > 3 > cash Flow > cash From Financing
6144000
Quarters > 3 > cash Flow > net Change In Cash
4243000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-16.14035663314687
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
83.01552480593992
Quarters > 3 > ratios > ROA
-47.57967019681803
Quarters > 3 > ratios > FCF
-10011000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
42
Annuals > 0 > quarter
2023-09-30
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
37717000
Annuals > 0 > income Statement > operating Income
-37717000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-35846000
Annuals > 0 > income Statement > net Income
-35846000
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
1644000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
-
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
-
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
-
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
-
Annuals > 0 > balance Sheet > equity
-
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-24138000
Annuals > 0 > cash Flow > depreciation
159000
Annuals > 0 > cash Flow > change In Working Capital
-9540000
Annuals > 0 > cash Flow > cash From Operations
-35586000
Annuals > 0 > cash Flow > capital Expenditures
63000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
23538000
Annuals > 0 > cash Flow > net Change In Cash
749000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-
Annuals > 0 > ratios > ROA
-
Annuals > 0 > ratios > FCF
-35649000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
37
Annuals > 1 > quarter
2022-09-30
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
154000
Annuals > 1 > income Statement > gross Profit
-154000
Annuals > 1 > income Statement > operating Expenses
56889000
Annuals > 1 > income Statement > operating Income
-56889000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-65153000
Annuals > 1 > income Statement > net Income
-65153000
Annuals > 1 > income Statement > eps
-124.96763266770114
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
521359
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-64999000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-8264000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
8907000
Annuals > 1 > balance Sheet > short Term Investments
4775000
Annuals > 1 > balance Sheet > receivables
2600000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
17706000
Annuals > 1 > balance Sheet > property Plant Equipment
2868000
Annuals > 1 > balance Sheet > total Assets
20679000
Annuals > 1 > balance Sheet > payables
13671000
Annuals > 1 > balance Sheet > short Term Debt
1342000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
32531000
Annuals > 1 > balance Sheet > equity
-11852000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-65153000
Annuals > 1 > cash Flow > depreciation
154000
Annuals > 1 > cash Flow > change In Working Capital
13764000
Annuals > 1 > cash Flow > cash From Operations
-45974000
Annuals > 1 > cash Flow > capital Expenditures
62000
Annuals > 1 > cash Flow > cash From Investing
32083000
Annuals > 1 > cash Flow > cash From Financing
6144000
Annuals > 1 > cash Flow > net Change In Cash
-7747000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-124.96763266770114
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
549.7215659804252
Annuals > 1 > ratios > ROA
-315.06842690652354
Annuals > 1 > ratios > FCF
-46036000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2021-09-30
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
148000
Annuals > 2 > income Statement > gross Profit
-148000
Annuals > 2 > income Statement > operating Expenses
47117000
Annuals > 2 > income Statement > operating Income
-47265000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-20282000
Annuals > 2 > income Statement > net Income
-20282000
Annuals > 2 > income Statement > eps
-44.12017428795799
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
459699
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-20134000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
26983000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
16654000
Annuals > 2 > balance Sheet > short Term Investments
37631000
Annuals > 2 > balance Sheet > receivables
4100000
Annuals > 2 > balance Sheet > inventories
1
Annuals > 2 > balance Sheet > total Current Assets
62864000
Annuals > 2 > balance Sheet > property Plant Equipment
3285000
Annuals > 2 > balance Sheet > total Assets
66762000
Annuals > 2 > balance Sheet > payables
2389000
Annuals > 2 > balance Sheet > short Term Debt
657000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
17386000
Annuals > 2 > balance Sheet > equity
49376000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-20282000
Annuals > 2 > cash Flow > depreciation
148000
Annuals > 2 > cash Flow > change In Working Capital
1765000
Annuals > 2 > cash Flow > cash From Operations
-41125000
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-11613000
Annuals > 2 > cash Flow > cash From Financing
53907000
Annuals > 2 > cash Flow > net Change In Cash
1169101
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-44.12017428795799
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
-41.07663642255347
Annuals > 2 > ratios > ROA
-30.379557233156586
Annuals > 2 > ratios > FCF
-41125000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2020-09-30
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
168249
Annuals > 3 > income Statement > gross Profit
-168249
Annuals > 3 > income Statement > operating Expenses
34071340
Annuals > 3 > income Statement > operating Income
-34239590
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-28155673
Annuals > 3 > income Statement > net Income
-28155673
Annuals > 3 > income Statement > eps
-98.95015533625731
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
284544
Annuals > 3 > income Statement > income Tax Expense
1
Annuals > 3 > income Statement > EBITDA
-27987420
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
6083917
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
15484899
Annuals > 3 > balance Sheet > short Term Investments
27005388
Annuals > 3 > balance Sheet > receivables
1100000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
46654902
Annuals > 3 > balance Sheet > property Plant Equipment
3720707
Annuals > 3 > balance Sheet > total Assets
51115579
Annuals > 3 > balance Sheet > payables
1806000
Annuals > 3 > balance Sheet > short Term Debt
1288527
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
38495834
Annuals > 3 > balance Sheet > equity
12619745
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-28155673
Annuals > 3 > cash Flow > depreciation
168249
Annuals > 3 > cash Flow > change In Working Capital
-2272052
Annuals > 3 > cash Flow > cash From Operations
-33186315
Annuals > 3 > cash Flow > capital Expenditures
5
Annuals > 3 > cash Flow > cash From Investing
-27404618
Annuals > 3 > cash Flow > cash From Financing
51891692
Annuals > 3 > cash Flow > net Change In Cash
-8699241
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-98.95015533625731
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
-223.10809766758362
Annuals > 3 > ratios > ROA
-55.082371266889105
Annuals > 3 > ratios > FCF
-33186320
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
12
Valuation > metrics > PE
-0.5006164055517883
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
93.05434971349193
Profitability > metrics > ROA
-82.19325153374233
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-5.220484753713839
Risk > final Score
9
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.7359747149791173
Liquidity > metrics > Quick Ratio
0.7359747149791173
Liquidity > final Score
47
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
55
Prev Profitabilities > 1
55
Prev Profitabilities > 2
55
Prev Risks > 0
-57
Prev Risks > 1
25
Prev Risks > 2
22
Prev Liquidities > 0
84
Prev Liquidities > 1
88
Prev Liquidities > 2
81
Updated At
2026-01-20T21:35:02.153Z
Earnings History > 0 > period
2023-09-30
Earnings History > 0 > report Date
2023-11-14
Earnings History > 0 > date
2023-09-30
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-0.5006
Earnings History > 0 > eps Estimate
-0.66
Earnings History > 0 > eps Difference
0.1594
Earnings History > 0 > surprise Percent
24.1515
Earnings History > 1 > period
2023-06-30
Earnings History > 1 > report Date
2023-08-14
Earnings History > 1 > date
2023-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-1.94
Earnings History > 1 > eps Estimate
-1.81
Earnings History > 1 > eps Difference
-0.13
Earnings History > 1 > surprise Percent
-7.1823
Earnings History > 2 > period
2023-03-31
Earnings History > 2 > report Date
2023-05-12
Earnings History > 2 > date
2023-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.69
Earnings History > 2 > eps Estimate
-10.83
Earnings History > 2 > eps Difference
10.14
Earnings History > 2 > surprise Percent
93.6288
Earnings History > 3 > period
2022-12-31
Earnings History > 3 > report Date
2023-03-16
Earnings History > 3 > date
2022-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-16.12
Earnings History > 3 > eps Estimate
-27.2
Earnings History > 3 > eps Difference
11.08
Earnings History > 3 > surprise Percent
40.7353
Earnings History > 4 > period
2022-09-30
Earnings History > 4 > report Date
2022-11-14
Earnings History > 4 > date
2022-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.43
Earnings History > 4 > eps Estimate
-0.23
Earnings History > 4 > eps Difference
-0.2
Earnings History > 4 > surprise Percent
-86.9565
Earnings History > 5 > period
2022-06-30
Earnings History > 5 > report Date
2022-08-15
Earnings History > 5 > date
2022-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.46
Earnings History > 5 > eps Estimate
-0.33
Earnings History > 5 > eps Difference
-0.13
Earnings History > 5 > surprise Percent
-39.3939
Earnings History > 6 > period
2022-03-31
Earnings History > 6 > report Date
2022-05-16
Earnings History > 6 > date
2022-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.51
Earnings History > 6 > eps Estimate
-0.3225
Earnings History > 6 > eps Difference
-0.1875
Earnings History > 6 > surprise Percent
-58.1395
Earnings History > 7 > period
2021-12-31
Earnings History > 7 > report Date
2022-03-24
Earnings History > 7 > date
2021-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.11
Earnings History > 7 > eps Estimate
-0.262
Earnings History > 7 > eps Difference
0.152
Earnings History > 7 > surprise Percent
58.0153
Earnings History > 8 > period
2021-09-30
Earnings History > 8 > report Date
2021-11-15
Earnings History > 8 > date
2021-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.13
Earnings History > 8 > eps Estimate
-0.1925
Earnings History > 8 > eps Difference
0.0625
Earnings History > 8 > surprise Percent
32.4675
Earnings History > 9 > period
2021-06-30
Earnings History > 9 > report Date
2021-08-13
Earnings History > 9 > date
2021-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.14
Earnings History > 9 > eps Estimate
-0.28
Earnings History > 9 > eps Difference
0.14
Earnings History > 9 > surprise Percent
50
Earnings History > 10 > period
2021-03-31
Earnings History > 10 > report Date
2021-05-14
Earnings History > 10 > date
2021-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.18
Earnings History > 10 > eps Estimate
-0.295
Earnings History > 10 > eps Difference
0.115
Earnings History > 10 > surprise Percent
38.9831
Earnings History > 11 > period
2020-12-31
Earnings History > 11 > report Date
2021-03-30
Earnings History > 11 > date
2020-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.23
Earnings History > 11 > eps Estimate
-0.315
Earnings History > 11 > eps Difference
0.085
Earnings History > 11 > surprise Percent
26.9841
Earnings History > 12 > period
2020-09-30
Earnings History > 12 > report Date
2020-11-13
Earnings History > 12 > date
2020-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.19
Earnings History > 12 > eps Estimate
-0.35
Earnings History > 12 > eps Difference
0.16
Earnings History > 12 > surprise Percent
45.7143
Earnings History > 13 > period
2020-06-30
Earnings History > 13 > report Date
2020-08-14
Earnings History > 13 > date
2020-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.88
Earnings History > 13 > eps Estimate
-0.33
Earnings History > 13 > eps Difference
-0.55
Earnings History > 13 > surprise Percent
-166.6667
Earnings History > 14 > period
2020-03-31
Earnings History > 14 > report Date
2020-05-15
Earnings History > 14 > date
2020-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.49
Earnings History > 14 > eps Estimate
-0.59
Earnings History > 14 > eps Difference
0.1
Earnings History > 14 > surprise Percent
16.9492
Earnings History > 15 > period
2019-12-31
Earnings History > 15 > report Date
2020-03-18
Earnings History > 15 > date
2019-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-1.11
Earnings History > 15 > eps Estimate
-0.79
Earnings History > 15 > eps Difference
-0.32
Earnings History > 15 > surprise Percent
-40.5063
Earnings History > 16 > period
2019-09-30
Earnings History > 16 > report Date
2019-11-12
Earnings History > 16 > date
2019-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.7
Earnings History > 16 > eps Estimate
-0.08
Earnings History > 16 > eps Difference
-0.62
Earnings History > 16 > surprise Percent
-775
Earnings History > 17 > period
2019-06-30
Earnings History > 17 > report Date
2019-08-09
Earnings History > 17 > date
2019-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-1.1
Earnings History > 17 > eps Estimate
-0.09
Earnings History > 17 > eps Difference
-1.01
Earnings History > 17 > surprise Percent
-1122.2222
Earnings History > 18 > period
2019-03-31
Earnings History > 18 > report Date
2019-05-10
Earnings History > 18 > date
2019-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
1.5
Earnings History > 18 > eps Estimate
-0.1
Earnings History > 18 > eps Difference
1.6
Earnings History > 18 > surprise Percent
1600
Earnings History > 19 > period
2018-12-31
Earnings History > 19 > report Date
2019-03-14
Earnings History > 19 > date
2018-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
0.7
Earnings History > 19 > eps Estimate
-0.1
Earnings History > 19 > eps Difference
0.8
Earnings History > 19 > surprise Percent
800
Earnings History > 20 > period
2018-09-30
Earnings History > 20 > report Date
2018-11-08
Earnings History > 20 > date
2018-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.6
Earnings History > 20 > eps Estimate
-0.1
Earnings History > 20 > eps Difference
-0.5
Earnings History > 20 > surprise Percent
-500
Earnings History > 21 > period
2018-06-30
Earnings History > 21 > report Date
2018-08-09
Earnings History > 21 > date
2018-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-2.7
Earnings History > 21 > eps Estimate
-0.1
Earnings History > 21 > eps Difference
-2.6
Earnings History > 21 > surprise Percent
-2600
Earnings History > 22 > period
2018-03-31
Earnings History > 22 > report Date
2018-05-10
Earnings History > 22 > date
2018-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-2.6
Earnings History > 22 > eps Estimate
-0.09
Earnings History > 22 > eps Difference
-2.51
Earnings History > 22 > surprise Percent
-2788.8889
Earnings History > 23 > period
2017-12-31
Earnings History > 23 > report Date
2018-03-15
Earnings History > 23 > date
2017-12-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.6
Earnings History > 23 > eps Estimate
-0.1
Earnings History > 23 > eps Difference
-0.5
Earnings History > 23 > surprise Percent
-500
Earnings History > 24 > period
2017-09-30
Earnings History > 24 > report Date
2017-11-08
Earnings History > 24 > date
2017-09-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.02
Earnings History > 24 > eps Estimate
-1.1
Earnings History > 24 > eps Difference
1.08
Earnings History > 24 > surprise Percent
98.1818
Earnings History > 25 > period
2017-06-30
Earnings History > 25 > report Date
2017-08-08
Earnings History > 25 > date
2017-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.07
Earnings History > 25 > eps Estimate
-1.6
Earnings History > 25 > eps Difference
1.53
Earnings History > 25 > surprise Percent
95.625
Earnings History > 26 > period
2017-03-31
Earnings History > 26 > report Date
2017-05-09
Earnings History > 26 > date
2017-03-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.15
Earnings History > 26 > eps Estimate
-1.6
Earnings History > 26 > eps Difference
1.45
Earnings History > 26 > surprise Percent
90.625
Earnings History > 27 > period
2016-12-31
Earnings History > 27 > report Date
2017-03-15
Earnings History > 27 > date
2016-12-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
0.1
Earnings History > 27 > eps Estimate
-1.97
Earnings History > 27 > eps Difference
2.07
Earnings History > 27 > surprise Percent
105.0761
Earnings History > 28 > period
2016-09-30
Earnings History > 28 > report Date
2016-11-09
Earnings History > 28 > date
2016-09-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-2.8
Earnings History > 28 > eps Estimate
-2.05
Earnings History > 28 > eps Difference
-0.75
Earnings History > 28 > surprise Percent
-36.5854
Earnings History > 29 > period
2016-06-30
Earnings History > 29 > report Date
2016-08-11
Earnings History > 29 > date
2016-06-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.35
Earnings History > 29 > eps Estimate
-213.33
Earnings History > 29 > eps Difference
212.98
Earnings History > 29 > surprise Percent
99.8359
Earnings History > 30 > period
2016-03-31
Earnings History > 30 > report Date
2016-05-10
Earnings History > 30 > date
2016-03-31
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.35
Earnings History > 30 > eps Estimate
-196
Earnings History > 30 > eps Difference
195.65
Earnings History > 30 > surprise Percent
99.8214
Earnings History > 31 > period
2015-12-31
Earnings History > 31 > report Date
2016-03-15
Earnings History > 31 > date
2015-12-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.32
Earnings History > 31 > eps Estimate
-2.3
Earnings History > 31 > eps Difference
1.98
Earnings History > 31 > surprise Percent
86.087
Earnings History > 32 > period
2015-09-30
Earnings History > 32 > report Date
2015-11-12
Earnings History > 32 > date
2015-09-30
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.28
Earnings History > 32 > eps Estimate
-2.25
Earnings History > 32 > eps Difference
1.97
Earnings History > 32 > surprise Percent
87.5556
Earnings History > 33 > period
2015-06-30
Earnings History > 33 > report Date
2015-08-13
Earnings History > 33 > date
2015-06-30
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.22
Earnings History > 33 > eps Estimate
-2.35
Earnings History > 33 > eps Difference
2.13
Earnings History > 33 > surprise Percent
90.6383
Earnings History > 34 > period
2015-03-31
Earnings History > 34 > report Date
2015-05-15
Earnings History > 34 > date
2015-03-31
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-191.9451
Earnings History > 34 > eps Estimate
-
Earnings History > 34 > eps Difference
0
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2014-12-31
Earnings History > 35 > report Date
2015-03-06
Earnings History > 35 > date
2014-12-31
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-0.24
Earnings History > 35 > eps Estimate
-1.85
Earnings History > 35 > eps Difference
1.61
Earnings History > 35 > surprise Percent
87.027
Earnings History > 36 > period
2014-09-30
Earnings History > 36 > report Date
2014-11-17
Earnings History > 36 > date
2014-09-30
Earnings History > 36 > before After Market
-
Earnings History > 36 > currency
USD
Earnings History > 36 > eps Actual
-978.7033
Earnings History > 36 > eps Estimate
-
Earnings History > 36 > eps Difference
0
Earnings History > 36 > surprise Percent
-
ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus. The company also developing CF-370, an investigational anti-bacterial therapeutic candidate, which is in Phase 1 clinical trials to treat pseudomonas aeruginosa infections, such as ventilator associated pneumonia, blood stream infections, complicated urinary tract infections, and surgery carry infections. It also developing CF-296, an osteomyelitis and PJI which is in preclinical trailers for the treatment of joint infections. In addition, the company developing Exebacase for the treatment of persistent bacteremia caused by methicillin-resistant staphylococcus aureus in COVID-19 patients. Further, It develops CF-296, an engineered lysin, used for treatment of the invasive infections caused by staphylococcus aureus including biofilm-related infections in prosthetic joints and indwelling devices and osteomyelitis. The company has a license agreement with The Rockefeller University to identify novel lysin therapeutic candidates targeting gram-negative pathogens. ContraFect Corporation was incorporated in 2008 and is headquartered in Yonkers, New York. On December 4, 2023, ContraFect Corporation filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ACONTRAFECT CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) marketscreener.com
Read more →(Last Updated 2023-09-30)
Health Score
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of ContraFect Corporation
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2023-09-30
EPS Actual
-0.5006
EPS Estimate
-0.66
EPS Difference
0.1594
Surprise Percent
24.1515%
(Last Updated 2023-09-30)
(Last Updated 2023-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2023-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.